GLG LLC’s Exelixis EXEL Stock Holding History

GLG LLC’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-350,000	Closed	-$1.24M	–	676
2014 Q1	$1.24M	Buy	+350,000	New	+$2.38M	0.04%	428

Other funds holding EXEL

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

GLG LLC's EXEL Position: Q2 2014 in Review

GLG LLC sold out of Exelixis (EXEL) in Q2 2014, closing a stake of 350,000 shares — an estimated $1.24M sold.

GLG LLC first reported a position in EXEL in Q1 2014 and held it in 1 quarter. The position peaked at $1.24M in Q1 2014. 136 funds tracked by Wall St. Rank hold EXEL as of Q2 2014.

GLG LLC reported no remaining Exelixis position as of Q2 2014 after selling out during the quarter.
GLG LLC sold 350,000 Exelixis shares in Q2 2014, an estimated $1.24M.
GLG LLC first reported a position in Exelixis in Q1 2014 and held it in 1 quarter.
GLG LLC's Exelixis position peaked at $1.24M in Q1 2014.
136 funds tracked by Wall St. Rank held Exelixis as of Q2 2014.

Based on GLG LLC's 13F filing for Q2 2014, filed 14 Aug 2014.